# Prostate Cancer Patient Management With 18F-DCFPyL PET/CT

> **NCT03459820** · PHASE2,PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Sir Mortimer B. Davis - Jewish General Hospital** · enrollment: 1500 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** 18F-DCFPyL PET/CT

## Key facts

- **NCT ID:** NCT03459820
- **Lead sponsor:** Sir Mortimer B. Davis - Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2018-06-22
- **Primary completion:** 2027-06
- **Final completion:** 2028-06
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2023-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03459820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03459820, "Prostate Cancer Patient Management With 18F-DCFPyL PET/CT". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03459820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*